News Author: Jen Smith Publish date: October 31, 2015
ANAHEIM, CA—Interim results of a large study suggest a blood donor’s genetic background and frequency of donation influence
red blood cell (RBC) stor...
News Author: Jen Smith Publish date: October 30, 2015
Photo by Charles Haymond
ANAHEIM, CA—Lifting the lifetime ban on blood donations from men who have sex with men (MSM) has not altered the safety of...
News Author: Jen Smith Publish date: June 10, 2015
© ASCO/Scott Morgan
CHICAGO—A dual inhibitor of FLT3 and Axl may produce more durable responses than other FLT3 inhibitors and improve survival in ...
News Author: Jen Smith Publish date: June 6, 2015
the 2015 ASCO Annual Meeting
© ASCO/Max Gersh
CHICAGO—A CD19-targeted chimeric antigen receptor (CAR) T-cell therapy can provide durable complete ...
News Author: Jen Smith Publish date: June 5, 2015
© ASCO/Max Gersh
CHICAGO—Allogeneic and autologous transplants produce similar survival rates when used as first-line therapy in younger patients w...
News Author: Jen Smith Publish date: June 5, 2015
©ASCO/Rodney White
CHICAGO—A 3-drug combination is safe and highly active in certain patients with relapsed B-cell malignancies, according to a spe...
News Author: Jen Smith Publish date: June 4, 2015
© ASCO/Rodney White
CHICAGO—Researchers say they have identified 3 leukemia stem cell (LSC) phenotypes that are correlated with cytogenetic/molecul...
News Author: Jen Smith Publish date: May 24, 2015
PHILADELPHIA—A DNA-dependent protein kinase (DNA-PK) inhibitor can sensitize chronic lymphocytic leukemia (CLL) cells to chemotherapy, according to
p...
News Author: Jen Smith Publish date: May 12, 2015
Their experiments showed that certain diffuse large B-cell lymphoma (DLBCL) cell lines were sensitive to CUDC-427, and others were not.
However, co...
News Author: Jen Smith Publish date: May 9, 2015
In xenograft models of various ALL subtypes, ABT-199 produced an objective response rate below 30%.
However, additional analyses unearthed informat...
News Author: Jen Smith Publish date: May 7, 2015
PHILADELPHIA—Preclinical research suggests a novel agent has preferential activity in acute myeloid leukemia (AML) with FMS-like tyrosine kinase 3 int...
News Author: Jen Smith Publish date: May 6, 2015
pseudopodia to engulf particles
PHILADELPHIA—New research suggests the prognostic value of tumor-associated macrophages (TAMs) is disease-specific ...
News Author: Jen Smith Publish date: April 30, 2015
PHILADELPHIA—A retrospective study has revealed factors that appear to influence a person’s susceptibility to Waldenström’s macroglobulinemia (WM)/...
News Author: Jen Smith Publish date: April 29, 2015
PHILADELPHIA—Two multikinase inhibitors (MKIs) can treat chronic myeloid leukemia (CML) that is resistant to other inhibitors, according to preclinica...
News Author: Jen Smith Publish date: April 28, 2015
Convention Center, site of the
AACR Annual Meeting 2015
PHILADELPHIA—When current treatment approaches failed to save a young patient with non-Hod...
